A carregar...
Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China
A split-virion trivalent inactivated influenza vaccine produced according to the Chinese pharmacopeia (Shz-IIV3) has been commercially available in China since 2014. Here, we describe the results of a phase IV open-label trial to describe the immunogenicity and safety of the 2014–2015 Northern Hemis...
Na minha lista:
| Publicado no: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5489275/ https://ncbi.nlm.nih.gov/pubmed/28301266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1285475 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|